Start Date
May 31, 1996
Study Completion Date
April 30, 2004
allogeneic tumor cell vaccine
recombinant interferon alfa
sargramostim
cyclophosphamide
St. Vincent Medical Center - Los Angeles, Los Angeles
St. Vincent Medical Center - Los Angeles
OTHER